Literature DB >> 29363454

Effect of Health Care on Quality of Life among Human Immunodeficiency Virus Infected Adults With and Without Visceral Leishmaniasis in northwest Ethiopia: A Longitudinal Follow-Up Study.

Mekuriaw Alemayehu1, Mamo Wubshet2, Nebiyu Mesfin3, Abebaw Gebayehu4.   

Abstract

There has been a scarcity of data on the effect of health care on the quality of life (QoL) of human immunodeficiency virus (HIV)- and visceral leishmaniasis (VL)- coinfected patients over time. We sought to assess the change that health care brings about in the QoL of HIV patients with and without VL and its predictors in 6 months. A total of 465 HIV patients without VL and 125 HIV-VL-coinfected patients were enrolled in the longitudinal follow-up study from October 2015 to September 2016. Data on QoL at baseline and in 6 months were collected by trained nurses through face-to-face interviews using a short Amharic version of World Health Organization QoL instrument for HIV clients. Multiple linear regressions were used to assess the predictors of health-related QoL. There was an improvement in all of the domains of QoL at the sixth month follow-up compared with the baseline for both groups of patients (P < 0.001). Lack of social support and income were associated with the low improvement in QoL in most of the domains in both groups. Compared with patients having severe acute malnutrition, patients having moderate acute malnutrition and normal nutritional status were better in most of the QoL domains in both groups of patients. Both antiretroviral and anti-VL treatments showed improvement in all dimensions of QoL. Income, social support, and nutritional status were the predictors for most of the QoL domains.

Entities:  

Mesh:

Year:  2018        PMID: 29363454      PMCID: PMC5930889          DOI: 10.4269/ajtmh.17-0458

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  28 in total

1.  Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile.

Authors:  Robert W Burgoyne; Sean B Rourke; Dean M Behrens; Irving E Salit
Journal:  AIDS Behav       Date:  2004-06

2.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

3.  Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study.

Authors:  V Pintado; P Martín-Rabadán; M L Rivera; S Moreno; E Bouza
Journal:  Medicine (Baltimore)       Date:  2001-01       Impact factor: 1.889

4.  Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication.

Authors:  D Wolday; H Akuffo; A Demissie; S Britton
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study.

Authors:  A Carr; J Chuah; J Hudson; M French; J Hoy; M Law; D Sayer; S Emery; D A Cooper
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

6.  Quality of life in people living with HIV/AIDS in Lebanon.

Authors:  Sarah Abboud; Samar Noureddine; Huda Abu-Saad Huijer; Jocelyn DeJong; Jacques Mokhbat
Journal:  AIDS Care       Date:  2010-06

7.  Gender differences in health-related quality of life in patients with HIV/AIDS.

Authors:  Joseph M Mrus; Paige L Williams; Joel Tsevat; Susan E Cohn; Albert W Wu
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

8.  An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART.

Authors:  J Jelsma; E Maclean; J Hughes; X Tinise; M Darder
Journal:  AIDS Care       Date:  2005-07

9.  Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection.

Authors:  P T Nieuwkerk; E H Gisolf; M H Reijers; J M Lange; S A Danner; M A Sprangers
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

10.  Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia.

Authors:  Mekuriaw Alemayehu; Mamo Wubshet; Nebiyu Mesfin; Aschalew Tamiru; Abebaw Gebayehu
Journal:  Health Qual Life Outcomes       Date:  2017-08-30       Impact factor: 3.186

View more
  3 in total

1.  Stakeholders' views and perspectives on treatments of visceral leishmaniasis and their outcomes in HIV-coinfected patients in East Africa and South-East Asia: A mixed methods study.

Authors:  Joanne Khabsa; Saurabh Jain; Amena El-Harakeh; Cynthia Rizkallah; Dhruv K Pandey; Nigus Manaye; Gladys Honein-AbouHaidar; Christine Halleux; Daniel Argaw Dagne; Elie A Akl
Journal:  PLoS Negl Trop Dis       Date:  2022-08-15

2.  The impact of leishmaniasis on mental health and psychosocial well-being: A systematic review.

Authors:  Malini Pires; Barry Wright; Paul M Kaye; Virgínia da Conceição; Rachel C Churchill
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

3.  Major depressive disorder and its association with adherence to antiretroviral therapy and quality of life: cross-sectional survey of people living with HIV/AIDS in Northwest Ethiopia.

Authors:  Biksegn Asrat; Crick Lund; Fentie Ambaw; Emily Claire Garman; Marguerite Schneider
Journal:  BMC Psychiatry       Date:  2020-09-24       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.